{"id":"https://genegraph.clinicalgenome.org/r/84fceb8b-d7e2-485e-9bfb-88c074d9992av1.1","type":"EvidenceStrengthAssertion","dc:description":"**Note: In September 2021, the ClinGen Epilepsy GCEP opted to change the disease term on this curation from Progressive Myoclonic Epilepsy to Epilepsy. The evidence summary below reflects this change. The original evidence and conclusion remains the same; therefore, the original date of approval has not been changed. **\n\nPRICKLE1 was reported in relation to autosomal dominant progressive myoclonic epilepsy (PME) in 2019 by Algahtani et al (PMID: 31035234). However, the phenotype described, presence of unaffected carriers, and allele frequency of the variant identified were not consistent with AD PME. Additional probands in whom a heterozygous PRICKLE1 variant was identified had epileptic phenotypes inconsistent with PME (21276947, 31875159, 29790814). No case-level evidence supports this gene-disease relationship. Of note, one case of a de novo variant in PRICKLE1 causing autosomal dominant complex neurodevelopmental disorder, including a seizure phenotype, has been reported (29790814). PRICKLE1 has also been assessed for autosomal recessive progressive myoclonic epilepsy by the ClinGen Epilepsy Expert Panel and found to have a Limited classification. In summary, there is convincing evidence disputing the relationship between PRICKLE1 and autosomal dominant epilepsy. More evidence is needed to either support or refute the role PRICKLE1 plays in this disease. This classification was approved by the ClinGen Epilepsy Expert Panel on 9/1/2020.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/84fceb8b-d7e2-485e-9bfb-88c074d9992a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","changes":[{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-09-01T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2021-09-21T12:51:01.069Z","role":"Publisher"}],"curationReasonDescription":"Upon expert review, there is a lack of convincing genetic evidence to support an association between PRICKLE1 and AD epilepsy.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01ea9c63-8050-4556-942e-3fe50e18f2a1","type":"EvidenceLine","dc:description":"No supporting functional evidence available, inconsistent phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01ea9c63-8050-4556-942e-3fe50e18f2a1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21276947","allele":{"id":"https://genegraph.clinicalgenome.org/r/9ee222ea-fb3d-4f33-a2da-42b95f193688","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.1414T>C (p.Tyr472His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342748"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/33f7989c-750e-44b8-85cd-b6e50f8c2a0b","type":"EvidenceLine","dc:description":"No supporting functional evidence available, inconsistent phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33f7989c-750e-44b8-85cd-b6e50f8c2a0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21276947","allele":{"id":"https://genegraph.clinicalgenome.org/r/9de3a25f-092e-4d78-bb72-142e4592afb7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.431G>A (p.Arg144His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA316976"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f5e33ede-bd37-466e-9d63-40f9a342669f","type":"EvidenceLine","dc:description":"No functional data, unconvincing phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5e33ede-bd37-466e-9d63-40f9a342669f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31035234","allele":{"id":"https://genegraph.clinicalgenome.org/r/deaca138-dc02-4983-9914-8f7eaca18541","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.251G>A (p.Arg84Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6519942"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/11fbc2a1-9cb7-42b7-8db6-6de450318737","type":"EvidenceLine","dc:description":"No functional data, unconvincing phenotype and high allele frequency: 6/18394 (0.03%) of East Asian alleles in gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/11fbc2a1-9cb7-42b7-8db6-6de450318737_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31875159","allele":{"id":"https://genegraph.clinicalgenome.org/r/2452f0e5-6fc1-4d17-a2a9-4637a50ac92d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.1621G>T (p.Ala541Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA6519729"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b7c2486e-4fd1-4b53-8d73-b2d3a8d76f8b","type":"EvidenceLine","dc:description":"Missense variant with no supporting functional evidence. Phenotype closer to complex neurodevelopmental disorder","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7c2486e-4fd1-4b53-8d73-b2d3a8d76f8b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29790814","allele":{"id":"https://genegraph.clinicalgenome.org/r/1fddaee4-5cf2-4cc8-8890-b19046e86346","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_153026.3(PRICKLE1):c.1444G>A (p.Asp482Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA384441679"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/07f21c8e-5a23-41b4-9bac-1a1491297100","type":"EvidenceLine","dc:description":"No functional data, unconvincing phenotype and high allele frequency: 6/18394 (0.03%) of East Asian alleles in gnomAD. Patient also carried a second P/LP variant in TSC2","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07f21c8e-5a23-41b4-9bac-1a1491297100_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31875159","allele":{"id":"https://genegraph.clinicalgenome.org/r/2452f0e5-6fc1-4d17-a2a9-4637a50ac92d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/8904bd83-48e9-4873-89c9-0cfdb0dceb3d","type":"EvidenceLine","dc:description":"No functional data, unconvincing phenotype and high allele frequency: 6/18394 (0.03%) of East Asian alleles in gnomAD","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8904bd83-48e9-4873-89c9-0cfdb0dceb3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31875159","allele":{"id":"https://genegraph.clinicalgenome.org/r/2452f0e5-6fc1-4d17-a2a9-4637a50ac92d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14336c10-6f36-4280-a597-bc9fac918a49_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31035234","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/14336c10-6f36-4280-a597-bc9fac918a49","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/20f8dff9-4c95-48ab-b8ae-6045badef6c1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31035234","rdfs:label":"Family 1 proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":50,"allele":{"id":"https://genegraph.clinicalgenome.org/r/deaca138-dc02-4983-9914-8f7eaca18541"},"detectionMethod":"WES","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001260","obo:HP_0001250","obo:HP_0001310","obo:HP_0100543","obo:HP_0001251","obo:HP_0001337"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f5e33ede-bd37-466e-9d63-40f9a342669f_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0001250","obo:HP_0001260","obo:HP_0001310","obo:HP_0100543","obo:HP_0001337","obo:HP_0001251"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/20f8dff9-4c95-48ab-b8ae-6045badef6c1"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b01b250d-bdc0-4c8e-9cf1-cd4e8df54f14","type":"EvidenceLine","dc:description":"Patient also carried a second P/LP variant in TSC2","calculatedScore":0.1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b01b250d-bdc0-4c8e-9cf1-cd4e8df54f14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31875159","allele":{"id":"https://genegraph.clinicalgenome.org/r/c40be90b-7f8e-47a8-9bcc-14ea77853c7b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000548.5(TSC2):c.3527C>T (p.Pro1176Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA047314"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/995f69b9-d128-43a2-ad99-d3c10977a11a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed73d490-871f-4842-9fb5-eda26c3119c6","type":"Finding","dc:description":"Prickle1 expression was observed in murine thalamus, hippocampus, cerebral cortex and cerebellumâ€“ areas of the brain thought to be involved in generating zeizures and ataxia. Co-staining these tissues with a neuron-specific marker NeuN and the glia-specific marker GFAP showed Prickles in specifically expressed in neurons but not in glia.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18976727","rdfs:label":"Prickle1 expression in the postnatal murine brain","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4d1b75a1-52b3-4a46-9189-a7f1a6464b9a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1543884-5f52-4563-a8bd-8c32dc612e6b","type":"Finding","dc:description":"Mouse Prickle1 and Prickle2 are continually expressed in the brain throughout the embryonic stages and are observed to be specifically expressed in the postmitotic neurons. Mouse Pk1 transcripts are detected in the subplate and cortical plate at E17.5, when majority of cortical neurons are undergoing maturation. Pk1 is also expressed in other brain areas such as hippocampus and non-neural tissues as well such as lens.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17868671","rdfs:label":"Mouse Prickle1 expressed in postmitotic neurons","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/45309681-b782-41ce-bd4c-06ab87ad5799","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66f50aed-e39b-42d3-9160-cf2b11e63c28","type":"FunctionalAlteration","dc:description":"Prickle1 depletion effectively decreases the neurite outgrowth levels of mouse neuroblastoma Neuro2a cells. These results indicate that mouse Prickle1 possibly regulate positive neurite formation during brain development.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17868671","rdfs:label":"Decrease in neurite outgrowth levels of mouse neuroblastoma"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/71a3c632-fd63-4103-a069-5e9e413043e7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/101d35f5-5ca7-4cef-bf5f-34ad166a5204","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67114b37-e400-4c0c-8ef5-8029a46e7bd3","type":"Finding","dc:description":"Seizure threshold was tested via the maximal electroconvulsive seizure threshold (MEST) test, which scores the occurrence of tonic hind- limb seizures at a specific amperage of applied electrical shock. Prickle1+/-, mice displayed a decreased seizure threshold compared to that of wild- type littermates. \nPrickle1 -/+ mutants produced a seizure phenotype which was controlled by administering Valproic Acid, a drug used to treat patients scored in this curation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21276947","rdfs:label":"Decreased Seizure Threshold in Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Disputed","sequence":3387,"specifiedBy":"GeneValidityCriteria7","strengthScore":3.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/u9Vpy4O3otw","type":"GeneValidityProposition","disease":"obo:MONDO_0005027","gene":"hgnc:17019","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_71a3c632-fd63-4103-a069-5e9e413043e7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}